Hjem › Blærekreft › Maryland › Baltimore
Kliniske studier for Blærekreft i Baltimore, MD
24 studier for Blærekreft søker deltakere på steder i og rundt Baltimore (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
RekruttererFase 3
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- og 2 flere
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruttererFase 2
- Johns Hopkins University, Baltimore
DK222 Study at Hopkins
RekruttererFase 1
- Johns Hopkins Hospital, Baltimore
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RekruttererFase 1/2
- Oncology Research Pharmacy and lnvestigational Drug Service, Baltimore
- The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
- Johns Hopkins Hospital, Baltimore
- og 2 flere
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
RekruttererFase 3
- Johns Hopkins University ( Site 0843), Baltimore
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RekruttererFase 3
- Johns Hopkins Hospital, Baltimore
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
RekruttererFase 2
- Anne Arundel Urology, Annapolis · 22 mi unna
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RekruttererFase 1
- Johns Hopkins Kimmel Cancer Center, Baltimore
Measuring Surgical Recovery After Radical Cystectomy
RekruttererObservasjonsstudie
- John Hopkins Medical Institutions, Baltimore
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RekruttererFase 1/2
- John Hopkins Hospital, Baltimore
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
RekruttererFase 2/3
- Johns Hopkins Hospital, Baltimore
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RekruttererFase 2
- The John Hopkins Hospital, Baltimore
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
RekruttererFase 2
- Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
Bladder EpiCheck Product Development Study
RekruttererObservasjonsstudie
- Chesapeake Urology Research Associates, Towson · 8 mi unna
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekruttererFase 1
- Johns Hopkins - Sidney Kimmel Comprehensive Cancer Center, Baltimore
Renal Retention in High Grade Upper Tract Urothelial Cancer
RekruttererFase 2
- Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center, Baltimore
Image-Guided Gynecologic Brachytherapy
Rekrutterer
- The SKCCC at Johns Hopkins, Baltimore
Blue Light Cystoscopy With Cysview® Registry
RekruttererObservasjonsstudie
- Johns Hopkins Medicine, Baltimore
Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
Rekrutterer
- Johns Hopkins Hospital, Baltimore
- Johns Hopkins Hospital, Baltimore
Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection
RekruttererFase 3
- Johns Hopkins University School of Medicine, Baltimore
Evaluating Safety and Efficacy of Prostate-sparing Radical Cystectomy
Rekrutterer
- Johns Hopkins Hospital, Baltimore
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Towson · 8 mi unna
Gender Related Coping and Survivorship for Genitourinary Cancers
RekruttererObservasjonsstudie
- Johns Hopkins Hospital, Baltimore
Blærekreft-studier i andre byer
- New York City, NY35 studier
- Nashville, TN31 studier
- Houston, TX31 studier
- Dallas, TX27 studier
- Boston, MA26 studier
- Washington, DC26 studier
- Los Angeles, CA24 studier
- St. Louis, MO22 studier
- Philadelphia, PA21 studier
- Seattle, WA21 studier
- Edison, NJ21 studier
- Chicago, IL21 studier
Andre studier i Baltimore
- Ikke-småcellet lungekreft60 studier
- Brystkreft47 studier
- Prostatakreft43 studier
- Lungekreft40 studier
- Kreft (alle typer)37 studier
- Kolorektal kreft31 studier
- Pankreaskreft31 studier
- Metastatisk kreft28 studier
- Fedme25 studier
- Hjertesvikt24 studier
- Slag22 studier
- Eggstokkreft22 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.